[PDF][PDF] Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions
Immune checkpoint blockade has recently emerged as a promising therapeutic approach for
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
[引用][C] Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions
T Hato, L Goyal, TF Greten, DG Duda, AX Zhu - Hepatology, 2014 - cir.nii.ac.jp
Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future
directions | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
directions | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions.
T Hato, L Goyal, TF Greten, DG Duda… - Hepatology (Baltimore …, 2014 - europepmc.org
Immune checkpoint blockade has recently emerged as a promising therapeutic approach for
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions
T Hato, L Goyal, TF Greten, DG Duda, AX Zhu - Hepatology, 2014 - infona.pl
Immune checkpoint blockade has recently emerged as a promising therapeutic approach for
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions
T Hato, L Goyal, TF Greten, DG Duda, AX Zhu - Hepatology, 2014 - journals.lww.com
Immune checkpoint blockade has recently emerged as a promising therapeutic approach for
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions
T Hato, L Goyal, TF Greten… - Hepatology …, 2014 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint blockade has recently emerged as a promising therapeutic approach for
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
[HTML][HTML] Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions
T Hato, L Goyal, TF Greten, DG Duda… - Hepatology (Baltimore …, 2014 - ncbi.nlm.nih.gov
Immune checkpoint blockade has recently emerged as a promising therapeutic approach for
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions.
T Hato, L Goyal, TF Greten, DG Duda… - Hepatology (Baltimore …, 2014 - europepmc.org
Immune checkpoint blockade has recently emerged as a promising therapeutic approach for
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions
T Hato, L Goyal, TF Greten… - Hepatology …, 2014 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint blockade has recently emerged as a promising therapeutic approach for
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …
various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical …